SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6d04'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1G50_B_ESTB1600_1 (ESTROGEN RECEPTOR)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	LEU E 458 LEU E 457 GLY E 463 HIS E 464 LEU E 465	None	1.07A	1g50B-6d04E: undetectable	1g50B-6d04E: 16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1G50_C_ESTC2600_1 (ESTROGEN RECEPTOR)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 11	LEU E 458 LEU E 457 GLY E 463 HIS E 464 LEU E 465	None	1.07A	1g50C-6d04E: undetectable	1g50C-6d04E: 16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_C_CHDC3271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE III CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 8	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.71A	1v54C-6d04E: 5.1 1v54J-6d04E: 1.1	1v54C-6d04E: undetectable 1v54J-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_P_CHDP4271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE III CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 8	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.77A	1v54P-6d04E: 5.2 1v54W-6d04E: 1.1	1v54P-6d04E: undetectable 1v54W-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 8	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.70A	2dyrC-6d04E: 5.2 2dyrJ-6d04E: 1.1	2dyrC-6d04E: undetectable 2dyrJ-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 8	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.78A	2dyrP-6d04E: 5.2 2dyrW-6d04E: 1.1	2dyrP-6d04E: undetectable 2dyrW-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 8	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.83A	2eikP-6d04E: 5.2 2eikW-6d04E: undetectable	2eikP-6d04E: undetectable 2eikW-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 8	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.71A	2eilC-6d04E: 5.1 2eilJ-6d04E: undetectable	2eilC-6d04E: undetectable 2eilJ-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_W_CHDW1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 7	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.78A	2eimP-6d04E: 5.1 2eimW-6d04E: undetectable	2eimP-6d04E: undetectable 2eimW-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YJA_B_ESTB1550_1 (ESTROGEN RECEPTOR)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	LEU E 458 LEU E 457 GLY E 463 HIS E 464 LEU E 465	None	1.02A	2yjaB-6d04E: undetectable	2yjaB-6d04E: 16.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_P_CHDP1271_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 7	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.76A	3asnP-6d04E: 5.2 3asnW-6d04E: 1.1	3asnP-6d04E: undetectable 3asnW-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASO_P_CHDP1271_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 7	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.80A	3asoP-6d04E: 5.2 3asoW-6d04E: 1.1	3asoP-6d04E: undetectable 3asoW-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IJX_B_HCZB800_1 (GLUTAMATE RECEPTOR 2)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 10	LYS E 576 LEU E 580 SER E 582 ILE E 567 PRO E 568	None	1.19A	3ijxB-6d04E: undetectable 3ijxD-6d04E: undetectable	3ijxB-6d04E: 22.35 3ijxD-6d04E: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IJX_D_HCZD800_1 (GLUTAMATE RECEPTOR 2)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 9	ILE E 567 PRO E 568 LYS E 576 LEU E 580 SER E 582	None	1.23A	3ijxB-6d04E: undetectable 3ijxD-6d04E: undetectable	3ijxB-6d04E: 22.35 3ijxD-6d04E: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IK6_B_HCZB262_1 (GLUTAMATE RECEPTOR 2)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 10	ILE E 567 PRO E 568 LYS E 576 LEU E 580 SER E 582	None	1.16A	3ik6B-6d04E: undetectable 3ik6E-6d04E: undetectable	3ik6B-6d04E: 22.35 3ik6E-6d04E: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IK6_B_HCZB800_1 (GLUTAMATE RECEPTOR 2)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 10	LYS E 576 LEU E 580 SER E 582 ILE E 567 PRO E 568	None	1.10A	3ik6B-6d04E: undetectable 3ik6E-6d04E: undetectable	3ik6B-6d04E: 22.35 3ik6E-6d04E: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ILU_B_HFZB800_1 (GLUTAMATE RECEPTOR 2)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 10	LYS E 576 LEU E 580 SER E 582 ILE E 567 PRO E 568	None	1.09A	3iluB-6d04E: undetectable 3iluE-6d04E: undetectable	3iluB-6d04E: 22.35 3iluE-6d04E: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ILU_E_HFZE800_1 (GLUTAMATE RECEPTOR 2)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 11	ILE E 567 PRO E 568 LYS E 576 LEU E 580 SER E 582	None	1.10A	3iluB-6d04E: undetectable 3iluE-6d04E: undetectable	3iluB-6d04E: 22.35 3iluE-6d04E: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OHT_A_1N1A2000_1 (P38A)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	ASP E 323 ILE E 325 ILE E 303 ILE E 426 TYR E 321	None	1.15A	3ohtA-6d04E: undetectable 3ohtB-6d04E: undetectable	3ohtA-6d04E: 12.57 3ohtB-6d04E: 12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OLS_A_ESTA600_1 (ESTROGEN RECEPTOR BETA)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	LEU E 458 LEU E 457 GLY E 463 HIS E 464 LEU E 465	None	1.09A	3olsA-6d04E: undetectable	3olsA-6d04E: 12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	LEU E 458 LEU E 457 GLY E 463 HIS E 464 LEU E 465	None	1.01A	3q95A-6d04E: undetectable	3q95A-6d04E: 15.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A97_A_ZPCA1318_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 7	GLU E 255 ILE E 251 GLU E 380 TYR E 177	None	0.88A	4a97A-6d04E: 4.0	4a97A-6d04E: 14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A97_D_ZPCD1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 7	GLU E 255 ILE E 251 GLU E 380 TYR E 177	None	0.95A	4a97D-6d04E: 4.0	4a97D-6d04E: 14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A97_H_ZPCH1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 7	GLU E 255 ILE E 251 GLU E 380 TYR E 177	None	0.95A	4a97H-6d04E: undetectable	4a97H-6d04E: 14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J26_A_ESTA600_1 (ESTROGEN RECEPTOR BETA)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	LEU E 458 LEU E 457 GLY E 463 HIS E 464 LEU E 465	None	1.11A	4j26A-6d04E: undetectable	4j26A-6d04E: 12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PXM_A_ESTA2000_1 (ESTROGEN RECEPTOR)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	LEU E 458 LEU E 457 GLY E 463 HIS E 464 LEU E 465	None	1.02A	4pxmA-6d04E: undetectable	4pxmA-6d04E: 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QC6_B_KANB201_2 (BIFUNCTIONAL AAC/APH)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	3 / 3	LEU E 271 ASP E 268 TYR E 267	None	0.65A	4qc6B-6d04E: undetectable	4qc6B-6d04E: 16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_F_377F401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 7	GLU E 255 GLU E 380 TYR E 177 LEU E 443	None	1.14A	4twdF-6d04E: undetectable 4twdJ-6d04E: undetectable	4twdF-6d04E: 14.01 4twdJ-6d04E: 14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCI_A_ADNA2414_1 (RNA-DIRECTED RNA POLYMERASE L)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 6	GLU E 275 ARG E 282 PHE E 178 TYR E 383	None	1.31A	4uciA-6d04E: undetectable	4uciA-6d04E: 12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCI_B_ADNB2415_1 (RNA-DIRECTED RNA POLYMERASE L)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 7	GLU E 275 ARG E 282 PHE E 178 TYR E 383	None	1.30A	4uciB-6d04E: undetectable	4uciB-6d04E: 12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZZC_E_ACTE406_0 (PROTON-GATED ION CHANNEL)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 5	ILE E 327 ARG E 207 TYR E 430 GLU E 204	None	1.24A	4zzcE-6d04E: 3.8	4zzcE-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DXG_B_ESTB601_1 (ESTROGEN RECEPTOR)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 11	LEU E 458 LEU E 457 GLY E 463 HIS E 464 LEU E 465	None	0.96A	5dxgB-6d04E: undetectable	5dxgB-6d04E: 15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GS4_A_ESTA603_2 (ESTROGEN RECEPTOR)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 6	LEU E 443 LEU E 440 PHE E 435 LEU E 192	None	0.92A	5gs4A-6d04E: 1.7	5gs4A-6d04E: 16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IGI_A_ZITA402_2 (MACROLIDE 2'-PHOSPHOTRANSFERAS E)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 6	PRO E 411 GLU E 204 LEU E 307 TYR E 211	None	0.92A	5igiA-6d04E: undetectable	5igiA-6d04E: 12.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JH7_D_6K9D502_0 (TUBULIN BETA-2B CHAIN)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 11	ASN E 428 VAL E 395 SER E 398 TYR E 337 LEU E 440	None	1.24A	5jh7D-6d04E: undetectable	5jh7D-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LJB_A_RTLA201_0 (RETINOL-BINDING PROTEIN 1)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	TYR E 347 SER E 439 ARG E 387 TYR E 177 ILE E 384	None	1.16A	5ljbA-6d04E: undetectable	5ljbA-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LJC_A_RTLA201_0 (RETINOL-BINDING PROTEIN 1)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	TYR E 347 SER E 439 ARG E 387 TYR E 177 ILE E 384	None	1.17A	5ljcA-6d04E: undetectable	5ljcA-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_C_PCFC1801_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 9	LYS E 298 ILE E 299 ILE E 303 LEU E 306	None	0.70A	5vkqB-6d04E: 3.0 5vkqC-6d04E: 3.0	5vkqB-6d04E: undetectable 5vkqC-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X19_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 3)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 6	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.72A	5x19P-6d04E: 5.2	5x19P-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_P_CHDP304_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	4 / 7	LYS E 437 LEU E 440 PHE E 388 LEU E 392	None	0.78A	5x1fP-6d04E: 5.2 5x1fW-6d04E: undetectable	5x1fP-6d04E: undetectable 5x1fW-6d04E: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_B_AQ4B602_0 (CYTOCHROME P450 1A1)	6d04	RETICULOCYTE BINDING PROTEIN 2, PUTATIVE (Plasmodium vivax)	5 / 12	ILE E 296 ASN E 428 ASN E 300 ILE E 189 LYS E 394	None	1.27A	6dwnB-6d04E: undetectable	6dwnB-6d04E: 15.66

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1G50_B_ESTB1600_1","ESTROGEN RECEPTOR","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LEU E 458;LEU E 457;GLY E 463;HIS E 464;LEU E 465","None","1.07A","1g50B-6d04E:undetectable","1g50B-6d04E:16.31"],["1G50_C_ESTC2600_1","ESTROGEN RECEPTOR","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LEU E 458;LEU E 457;GLY E 463;HIS E 464;LEU E 465","None","1.07A","1g50C-6d04E:undetectable","1g50C-6d04E:16.31"],["1V54_C_CHDC3271_0","CYTOCHROME C OXIDASE POLYPEPTIDE III;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.71A","1v54C-6d04E:5.1;1v54J-6d04E:1.1","1v54C-6d04E:undetectable;1v54J-6d04E:undetectable"],["1V54_P_CHDP4271_0","CYTOCHROME C OXIDASE POLYPEPTIDE III;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.77A","1v54P-6d04E:5.2;1v54W-6d04E:1.1","1v54P-6d04E:undetectable;1v54W-6d04E:undetectable"],["2DYR_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.70A","2dyrC-6d04E:5.2;2dyrJ-6d04E:1.1","2dyrC-6d04E:undetectable;2dyrJ-6d04E:undetectable"],["2DYR_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.78A","2dyrP-6d04E:5.2;2dyrW-6d04E:1.1","2dyrP-6d04E:undetectable;2dyrW-6d04E:undetectable"],["2EIK_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.83A","2eikP-6d04E:5.2;2eikW-6d04E:undetectable","2eikP-6d04E:undetectable;2eikW-6d04E:undetectable"],["2EIL_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.71A","2eilC-6d04E:5.1;2eilJ-6d04E:undetectable","2eilC-6d04E:undetectable;2eilJ-6d04E:undetectable"],["2EIM_W_CHDW1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.78A","2eimP-6d04E:5.1;2eimW-6d04E:undetectable","2eimP-6d04E:undetectable;2eimW-6d04E:undetectable"],["2YJA_B_ESTB1550_1","ESTROGEN RECEPTOR","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LEU E 458;LEU E 457;GLY E 463;HIS E 464;LEU E 465","None","1.02A","2yjaB-6d04E:undetectable","2yjaB-6d04E:16.25"],["3ASN_P_CHDP1271_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.76A","3asnP-6d04E:5.2;3asnW-6d04E:1.1","3asnP-6d04E:undetectable;3asnW-6d04E:undetectable"],["3ASO_P_CHDP1271_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.80A","3asoP-6d04E:5.2;3asoW-6d04E:1.1","3asoP-6d04E:undetectable;3asoW-6d04E:undetectable"],["3IJX_B_HCZB800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LYS E 576;LEU E 580;SER E 582;ILE E 567;PRO E 568","None","1.19A","3ijxB-6d04E:undetectable;3ijxD-6d04E:undetectable","3ijxB-6d04E:22.35;3ijxD-6d04E:22.35"],["3IJX_D_HCZD800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"ILE E 567;PRO E 568;LYS E 576;LEU E 580;SER E 582","None","1.23A","3ijxB-6d04E:undetectable;3ijxD-6d04E:undetectable","3ijxB-6d04E:22.35;3ijxD-6d04E:22.35"],["3IK6_B_HCZB262_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"ILE E 567;PRO E 568;LYS E 576;LEU E 580;SER E 582","None","1.16A","3ik6B-6d04E:undetectable;3ik6E-6d04E:undetectable","3ik6B-6d04E:22.35;3ik6E-6d04E:22.35"],["3IK6_B_HCZB800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LYS E 576;LEU E 580;SER E 582;ILE E 567;PRO E 568","None","1.10A","3ik6B-6d04E:undetectable;3ik6E-6d04E:undetectable","3ik6B-6d04E:22.35;3ik6E-6d04E:22.35"],["3ILU_B_HFZB800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LYS E 576;LEU E 580;SER E 582;ILE E 567;PRO E 568","None","1.09A","3iluB-6d04E:undetectable;3iluE-6d04E:undetectable","3iluB-6d04E:22.35;3iluE-6d04E:22.35"],["3ILU_E_HFZE800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"ILE E 567;PRO E 568;LYS E 576;LEU E 580;SER E 582","None","1.10A","3iluB-6d04E:undetectable;3iluE-6d04E:undetectable","3iluB-6d04E:22.35;3iluE-6d04E:22.35"],["3OHT_A_1N1A2000_1","P38A;P38A","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"ASP E 323;ILE E 325;ILE E 303;ILE E 426;TYR E 321","None","1.15A","3ohtA-6d04E:undetectable;3ohtB-6d04E:undetectable","3ohtA-6d04E:12.57;3ohtB-6d04E:12.57"],["3OLS_A_ESTA600_1","ESTROGEN RECEPTOR BETA","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LEU E 458;LEU E 457;GLY E 463;HIS E 464;LEU E 465","None","1.09A","3olsA-6d04E:undetectable","3olsA-6d04E:12.92"],["3Q95_A_ESLA700_1","ESTROGEN RECEPTOR","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LEU E 458;LEU E 457;GLY E 463;HIS E 464;LEU E 465","None","1.01A","3q95A-6d04E:undetectable","3q95A-6d04E:15.70"],["4A97_A_ZPCA1318_1","CYS-LOOP LIGAND-GATED ION CHANNEL","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"GLU E 255;ILE E 251;GLU E 380;TYR E 177","None","0.88A","4a97A-6d04E:4.0","4a97A-6d04E:14.01"],["4A97_D_ZPCD1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"GLU E 255;ILE E 251;GLU E 380;TYR E 177","None","0.95A","4a97D-6d04E:4.0","4a97D-6d04E:14.01"],["4A97_H_ZPCH1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"GLU E 255;ILE E 251;GLU E 380;TYR E 177","None","0.95A","4a97H-6d04E:undetectable","4a97H-6d04E:14.01"],["4J26_A_ESTA600_1","ESTROGEN RECEPTOR BETA","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LEU E 458;LEU E 457;GLY E 463;HIS E 464;LEU E 465","None","1.11A","4j26A-6d04E:undetectable","4j26A-6d04E:12.92"],["4PXM_A_ESTA2000_1","ESTROGEN RECEPTOR","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LEU E 458;LEU E 457;GLY E 463;HIS E 464;LEU E 465","None","1.02A","4pxmA-6d04E:undetectable","4pxmA-6d04E:16.00"],["4QC6_B_KANB201_2","BIFUNCTIONAL AAC\/APH","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",3,"LEU E 271;ASP E 268;TYR E 267","None","0.65A","4qc6B-6d04E:undetectable","4qc6B-6d04E:16.38"],["4TWD_F_377F401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"GLU E 255;GLU E 380;TYR E 177;LEU E 443","None","1.14A","4twdF-6d04E:undetectable;4twdJ-6d04E:undetectable","4twdF-6d04E:14.01;4twdJ-6d04E:14.01"],["4UCI_A_ADNA2414_1","RNA-DIRECTED RNA POLYMERASE L","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"GLU E 275;ARG E 282;PHE E 178;TYR E 383","None","1.31A","4uciA-6d04E:undetectable","4uciA-6d04E:12.74"],["4UCI_B_ADNB2415_1","RNA-DIRECTED RNA POLYMERASE L","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"GLU E 275;ARG E 282;PHE E 178;TYR E 383","None","1.30A","4uciB-6d04E:undetectable","4uciB-6d04E:12.74"],["4ZZC_E_ACTE406_0","PROTON-GATED ION CHANNEL","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"ILE E 327;ARG E 207;TYR E 430;GLU E 204","None","1.24A","4zzcE-6d04E:3.8","4zzcE-6d04E:undetectable"],["5DXG_B_ESTB601_1","ESTROGEN RECEPTOR","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"LEU E 458;LEU E 457;GLY E 463;HIS E 464;LEU E 465","None","0.96A","5dxgB-6d04E:undetectable","5dxgB-6d04E:15.64"],["5GS4_A_ESTA603_2","ESTROGEN RECEPTOR","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LEU E 443;LEU E 440;PHE E 435;LEU E 192","None","0.92A","5gs4A-6d04E:1.7","5gs4A-6d04E:16.38"],["5IGI_A_ZITA402_2","MACROLIDE 2'-PHOSPHOTRANSFERASE","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"PRO E 411;GLU E 204;LEU E 307;TYR E 211","None","0.92A","5igiA-6d04E:undetectable","5igiA-6d04E:12.79"],["5JH7_D_6K9D502_0","TUBULIN BETA-2B CHAIN","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"ASN E 428;VAL E 395;SER E 398;TYR E 337;LEU E 440","None","1.24A","5jh7D-6d04E:undetectable","5jh7D-6d04E:undetectable"],["5LJB_A_RTLA201_0","RETINOL-BINDING PROTEIN 1","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"TYR E 347;SER E 439;ARG E 387;TYR E 177;ILE E 384","None","1.16A","5ljbA-6d04E:undetectable","5ljbA-6d04E:undetectable"],["5LJC_A_RTLA201_0","RETINOL-BINDING PROTEIN 1","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"TYR E 347;SER E 439;ARG E 387;TYR E 177;ILE E 384","None","1.17A","5ljcA-6d04E:undetectable","5ljcA-6d04E:undetectable"],["5VKQ_C_PCFC1801_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 298;ILE E 299;ILE E 303;LEU E 306","None","0.70A","5vkqB-6d04E:3.0;5vkqC-6d04E:3.0","5vkqB-6d04E:undetectable;5vkqC-6d04E:undetectable"],["5X19_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 3","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.72A","5x19P-6d04E:5.2","5x19P-6d04E:undetectable"],["5X1F_P_CHDP304_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",4,"LYS E 437;LEU E 440;PHE E 388;LEU E 392","None","0.78A","5x1fP-6d04E:5.2;5x1fW-6d04E:undetectable","5x1fP-6d04E:undetectable;5x1fW-6d04E:undetectable"],["6DWN_B_AQ4B602_0","CYTOCHROME P450 1A1","6d04","RETICULOCYTE BINDING PROTEIN 2, PUTATIVE","Plasmodium vivax",5,"ILE E 296;ASN E 428;ASN E 300;ILE E 189;LYS E 394","None","1.27A","6dwnB-6d04E:undetectable","6dwnB-6d04E:15.66"]]